Millennium Management LLC cut its holdings in shares of Rentokil Initial plc (NYSE:RTO - Free Report) by 38.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 44,362 shares of the company's stock after selling 27,408 shares during the quarter. Millennium Management LLC's holdings in Rentokil Initial were worth $1,123,000 as of its most recent SEC filing.
A number of other large investors have also added to or reduced their stakes in RTO. SG Americas Securities LLC bought a new position in Rentokil Initial during the fourth quarter worth $213,000. Janney Montgomery Scott LLC bought a new position in shares of Rentokil Initial during the fourth quarter worth approximately $257,000. Blue Trust Inc. increased its stake in shares of Rentokil Initial by 140.4% during the fourth quarter. Blue Trust Inc. now owns 2,402 shares of the company's stock worth $60,000 after purchasing an additional 1,403 shares during the period. CENTRAL TRUST Co lifted its holdings in Rentokil Initial by 15,208.3% during the 4th quarter. CENTRAL TRUST Co now owns 1,837 shares of the company's stock worth $47,000 after purchasing an additional 1,825 shares during the last quarter. Finally, Iridian Asset Management LLC CT boosted its stake in Rentokil Initial by 1.2% in the 4th quarter. Iridian Asset Management LLC CT now owns 728,764 shares of the company's stock valued at $18,452,000 after purchasing an additional 8,969 shares during the period. Institutional investors own 9.91% of the company's stock.
Wall Street Analysts Forecast Growth
RTO has been the topic of several recent research reports. Sanford C. Bernstein cut Rentokil Initial from a "market perform" rating to an "underperform" rating in a research report on Thursday, May 15th. Deutsche Bank Aktiengesellschaft restated a "buy" rating on shares of Rentokil Initial in a research note on Friday, March 7th. One analyst has rated the stock with a sell rating, two have given a hold rating, one has given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, Rentokil Initial has a consensus rating of "Moderate Buy".
View Our Latest Research Report on RTO
Rentokil Initial Price Performance
Shares of NYSE RTO traded down $0.04 during midday trading on Friday, reaching $23.70. The company's stock had a trading volume of 322,622 shares, compared to its average volume of 783,663. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.96 and a current ratio of 1.04. The company has a market cap of $11.97 billion, a P/E ratio of 15.70, a P/E/G ratio of 7.95 and a beta of 0.95. The business's 50 day moving average price is $22.92 and its two-hundred day moving average price is $24.10. Rentokil Initial plc has a fifty-two week low of $19.60 and a fifty-two week high of $34.07.
Rentokil Initial Profile
(
Free Report)
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Featured Stories

Before you consider Rentokil Initial, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.
While Rentokil Initial currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.